Publications and reports

Find a list of publications and cancer reports that use data held by the Cancer Institute NSW.

Below is a list of publications that use data held by the Cancer Institute NSW.  

This includes:

  • NSW Cancer Registry
  • NSW Clinical Cancer Registry (2008–2012)
  • BreastScreen NSW
  • NSW Pap Test Register
  • Cancer Institute Tobacco Tracking Survey
Published date 06 June 2017
library_books A healthy diet before a diagnosis of ovarian cancer may be associated with improved ovarian cancer survival.
Published date 06 June 2017
library_books Risk of progression of colorectal cancer to metastatic disease was significantly higher for those initially diagnosed with regional disease and for older cases.
Published date 02 June 2017
library_books Aboriginal peoples with cancer have an elevated hazard of cancer death compared with non-Aboriginal people, after accounting for more advanced stage and competing causes of death.
Published date 01 June 2017
library_books Lung cancer incidence has remained relatively stable for women in the highest socioeconomic group but has increased for all other women in NSW.
Published date 26 May 2017
library_books In people diagnosed with haematological cancer and their support persons, unmet needs may mediate the interdependence of psychosocial experiences.
Published date 25 May 2017
library_books The low level of concordance with national guidelines for surgical management of melanoma resulted in overtreatment of many patients.
Published date 01 May 2017
library_books Global inequalities in survival from childhood leukaemia have narrowed with time but remain very wide for both acute lymphoblastic leukaemia and acute myeloid leukaemia.
Published date 28 April 2017
library_books Health care providers should consider providing additional education and skills-based interventions to support persons of haematological cancer survivors who experience increased symptoms of depression.
Published date 21 April 2017
library_books The post-treatment positron emission tomography scan appears to be of value in predicting both progression free survival and overall survival in T cell non-Hodgkin Lymphoma.